SR ONE CAPITAL MANAGEMENT, LP
CIK: 0001910264SEC EDGAR →
Portfolio Value
$706.4M
Holdings
13
As of
Q4 2025
New Positions
0
Closed Positions
1
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Zenas BioPharma, Inc | 5,037,854 | $182.9M | 25.90% |
| 2 | Arcellx, Inc. | 2,346,630 | $153.0M | 21.66% |
| 3 | CRISPR Therapeutics AG | 2,038,763 | $106.9M | 15.14% |
| 4 | Design Therapeutics, Inc. | 6,526,476 | $61.2M | 8.67% |
| 5 | Mineralys Therapeutics Inc. | 1,563,966 | $56.8M | 8.03% |
| 6 | ARS Pharmaceuticals, Inc. | 4,012,903 | $46.8M | 6.62% |
| 7 | ORIC Pharmaceuticals, Inc. | 4,514,929 | $37.8M | 5.34% |
| 8 | Alumis Inc. | 1,959,896 | $19.1M | 2.71% |
| 9 | Oruka Therapeutics, Inc | 430,330 | $13.0M | 1.85% |
| 10 | Oculis Holding AG | 641,022 | $12.8M | 1.81% |
Quarterly Changes
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 13 | $706.4M | 100.0% |